Selzentry | search
Click here to view Selzentry news from 60+ newspapers.
Bookmark or Share- SELZENTRY (MARAVIROC) label - Food and Drug AdministrationSELZENTRY is a CCR5 co-receptor antagonist indicated for combination antiretroviral treatment of adults infected with only CCR5-tropic HIV-1detectable, who have evidence of viral...
- Maraviroc - WikipediaMaraviroc, sold under the brand names Selzentry (US) and Celsentri (EU), is an antiretroviral medication used to treat HIV infection. [2][3] It is taken by mouth. [2][3] It is in the CCR5 receptor antagonist class. [2][3] It was approved for medical use in the United States in August 2007, [2] and in the European Union in September 2007. [3]
- Maraviroc Uses, Side Effects & Warnings - Drugs.comGeneric name: maraviroc [ ma-RAV-i-rok ] Brand name: Selzentry. Dosage forms: oral liquid (20 mg/mL), oral tablet (150 mg; 25 mg; 300 mg; 75 mg) Drug class: Chemokine receptor antagonist. Medically reviewed by Drugs.com on Oct 28, 2024. Written by Cerner Multum. Uses. Side effects. Warnings. Before taking. Dosage. Interactions. What is maraviroc?
- Maraviroc (Selzentry): Uses, Side Effects, Interactions & More - GoodRxMaraviroc (Selzentry) is a medication that's used in combination with other antiretroviral (ARV) therapy to treat CCR5-tropic human immunodeficiency virus (HIV) infections. It comes as oral tablets (both generic and brand) and solution (brand only) for adults and children weighing over 4 pounds.
- Selzentry: Uses, Dosage, Side Effects, Warnings - Drugs.comSelzentry is used to treat CCR5-tropic human immunodeficiency virus (HIV). Learn about side effects, interactions and indications.
More
